Rithin Nedumannil
11PUBLICATIONS
21CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Dec 18, 2025
Reduced burden of infection with consecutive day dosing of high dose cytarabine consolidation versus conventional dosing for acute myeloid leukemia.Alice J Liu, Emily Batterham, Rithin Nedumannil
|Jul 29, 2025
Time to complete remission is an independent determinant of survival after intensive chemotherapy in AML.Rithin Nedumannil, Michael Ashby, James Rowland
|Feb 10, 2025
Serial sensitive molecular detection of JAK2 V617F is predictive of relapse after allogeneic stem cell transplantation in patients with myelofibrosis.Rithin Nedumannil, Tal Karmi, Piers Blombery
|Jan 10, 2024
Arsenic-induced neurotoxicity in patients with acute promyelocytic leukaemia.Zoe Loh, Michael Ashby, Ellie Van Veldhuizen
|Sep 01, 2023
Consecutive day dosing of high-dose cytarabine consolidation over 3 days is resource-efficient and safe in older adult patients with acute myeloid leukemia.Rithin Nedumannil, Emily Batterham, Emily Harding
|Nov 02, 2022
Real-world utility of early measurable residual disease assessments by multi-parametric flow cytometry in adult patients with B-lymphoblastic leukemia receiving Hyper-CVAD induction chemotherapy.Rithin Nedumannil, David Ritchie, Ashish Bajel
Pageof 2
Frequent Collaborators
3 joint publications
Ashish Bajel
2 joint publications
Piers Blombery
2 joint publications
Andrew H Wei
2 joint publications
David S Ritchie
1 joint publications
Surender Juneja
1 joint publications
Melissa Ng Liet Hing
1 joint publications
Georgina L Ryland
1 joint publications
Michelle K Yong
1 joint publications
Slavisa Ninkovic
1 joint publications
Kah Lok Chan
